GF
COVS

Gabelli Funds’s Covisint Corporation COVS Stock Holding History

Gabelli Funds’s Portfolio COVS Stock Details COVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-217,410
Closed -$533K – 1159
2017
Q2 		$533K Buy
217,410
+12,334
+6% +$25.8K ﹤0.01% 992
2017
Q1 		$420K Hold
205,076
– – ﹤0.01% 1024
2016
Q4 		$390K Hold
205,076
– – ﹤0.01% 1039
2016
Q3 		$447K Hold
205,076
– – ﹤0.01% 1033
2016
Q2 		$447K Hold
205,076
– – ﹤0.01% 1039
2016
Q1 		$410K Hold
205,076
– – ﹤0.01% 1023
2015
Q4 		$513K Hold
205,076
– – ﹤0.01% 995
2015
Q3 		$441K Sell
205,076
-31,905
-13% -$87.7K ﹤0.01% 961
2015
Q2 		$775K Sell
236,981
-57,549
-20% -$136K ﹤0.01% 913
2015
Q1 		$598K Sell
294,530
-3,952
-1% -$9.22K ﹤0.01% 947
2014
Q4 		$791K Buy
+298,482
New +$855K ﹤0.01% 921

Gabelli Funds's COVS Position: Q3 2017 in Review

Gabelli Funds sold out of Covisint Corporation (COVS) in Q3 2017, closing a stake of 217,410 shares — an estimated $533K sold.

Gabelli Funds first reported a position in COVS in Q4 2014 and held it in 11 quarters. The position peaked at $791K in Q4 2014. 0 funds tracked by Wall St. Rank hold COVS as of Q3 2017.

  • Gabelli Funds reported no remaining Covisint Corporation position as of Q3 2017 after selling out during the quarter.
  • Gabelli Funds sold 217,410 Covisint Corporation shares in Q3 2017, an estimated $533K.
  • Gabelli Funds first reported a position in Covisint Corporation in Q4 2014 and held it in 11 quarters.
  • Gabelli Funds's Covisint Corporation position peaked at $791K in Q4 2014.
  • 0 funds tracked by Wall St. Rank held Covisint Corporation as of Q3 2017.

Based on Gabelli Funds's 13F filing for Q3 2017, filed 1 Nov 2017.